Victory Capital Management Inc Aptinyx Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.38 - $2.58 $53,336 - $362,128	-140,360 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$2.27 - $3.62 $318,617 - $508,103	140,360 New	140,360 $319,000
Q2 2020 Aug 07, 2020	SELL	$1.99 - $4.4 $8,312 - $18,378	-4,177 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.81 - $5.03 $1,295 - $3,601	-716 Reduced 14.63%	4,177 $9,000
Q4 2019 Feb 04, 2020	BUY	$2.84 - $4.25 $4,972 - $7,441	1,751 Added 55.73%	4,893 $20,000

Q3 2019 Nov 12, 2019	BUY	$3.0 - $4.08 $9,426 - $12,819	3,142 New	3,142 $11,000
Q1 2019 May 03, 2019	SELL	$3.99 - $19.33 $2.66 Million - $12.9 Million	-666,358 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$16.15 - $28.93 $2.27 Million - $4.07 Million	-140,631 Reduced 17.43%	666,358 $11 Million
Q3 2018 Nov 01, 2018	BUY	$20.21 - $31.85 $2.11 Million - $3.32 Million	104,297 Added 14.84%	806,989 $23.4 Million
Q2 2018 Aug 02, 2018	BUY	$19.83 - $24.17 $13.9 Million - $17 Million	702,692 New	702,692 $17 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.